Live Breaking News & Updates on Nasdaq Sana

Stay updated with breaking news from Nasdaq sana. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Comparing Sana Biotechnology (NASDAQ:SANA) and 4D Molecular Therapeutics (NASDAQ:FDMT)

Sana Biotechnology (NASDAQ:SANA – Get Free Report) and 4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability. Earnings and Valuation This table compares Sana […] ....

United States , Arbor Biotechnologies Inc , Harvard College , Cystic Fibrosis Foundation , Fd Therapeutics Inc , D Molecular Therapeutics Inc , Beam Therapeutics Inc , Sana Biotechnology Inc , Astellas Gene Therapies Inc , Sana Biotechnology , Get Free Report , Molecular Therapeutics , Molecular Therapeutic , Beam Therapeutics , Arbor Biotechnologies , Astellas Gene Therapies , Cystic Fibrosis , Sana Biotechnology Daily , Nasdaq Sana , Stock Comparison , Stock Analysis ,

Sana Biotechnology (NASDAQ:SANA) versus Vitro Diagnostics (OTCMKTS:VODG) Financial Review

Sana Biotechnology (NASDAQ:SANA – Get Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, earnings, valuation and dividends. Analyst Recommendations This is a summary of current […] ....

United States , Vitro Diagnostics Inc , Sana Biotechnology Inc , Fd Therapeutics Inc , Sana Biotechnology , Get Free Report , Vitro Diagnostics , Given Sana Biotechnology , Vitro Diagnostic , Hodgkin Lymphoma , Vitro Biopharma , Stem Cell , Drug Discovery , Sana Biotechnology Daily , Nasdaq Sana , Stock Comparison , Stock Analysis ,

Sana Biotechnology (NASDAQ:SANA) Raised to Buy at HC Wainwright

HC Wainwright upgraded shares of Sana Biotechnology (NASDAQ:SANA – Free Report) from a neutral rating to a buy rating in a report published on Tuesday morning, Marketbeat.com reports. They currently have $12.00 price objective on the stock. HC Wainwright also issued estimates for Sana Biotechnology’s FY2027 earnings at ($0.80) EPS and FY2028 earnings at ($0.64) […] ....

York Mellon Corp , Td Asset Management Inc , Sana Biotechnology Inc , Casdin Capital , Sana Biotechnology Company Profile , Sana Biotechnology , Free Report , Moderate Buy , Get Free Report , World Investors , Michigan Retirement System , New York Mellon Corp , Management Inc , Sana Biotechnology Daily , Nasdaq Sana , Hc Wainwright ,

Sana Biotechnology (NASDAQ:SANA) Shares Up 5.2%

Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report)’s stock price shot up 5.2% during mid-day trading on Thursday . The stock traded as high as $4.51 and last traded at $4.49. 173,675 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 1,210,195 shares. The stock had previously closed […] ....

Metlife Investment Management , Swiss National Bank , Sana Biotechnology Inc , Topco Ltd , Sana Biotechnology Company Profile , Blackrock Inc , Sana Biotechnology , Get Free Report , Biotechnology Trading Down , National Bank , Life Investment Management , Sana Biotechnology Daily , Nasdaq Sana ,